Explore the words cloud of the FibreNet project. It provides you a very rough idea of what is the project "FibreNet" about.
The following table provides information about the project.
| Coordinator |
TTY-SAATIO
There are not information about this coordinator. Please contact Fabio for more information, thanks. |
| Coordinator Country | Finland [FI] |
| Total cost | 3˙832˙629 € |
| EC max contribution | 3˙832˙629 € (100%) |
| Programme |
1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers) |
| Code Call | H2020-MSCA-ITN-2017 |
| Funding Scheme | MSCA-ITN-ETN |
| Starting year | 2017 |
| Duration (year-month-day) | from 2017-12-01 to 2021-11-30 |
Take a look of project's partnership.
| # | ||||
|---|---|---|---|---|
| 1 | TAMPEREEN KORKEAKOULUSAATIO SR | FI (TAMPERE) | coordinator | 807˙436.00 |
| 2 | TTY-SAATIO | FI (TAMPERE) | coordinator | 0.00 |
| 3 | KUNGLIGA TEKNISKA HOEGSKOLAN | SE (STOCKHOLM) | participant | 527˙318.00 |
| 4 | TECHNISCHE UNIVERSITAET GRAZ | AT (GRAZ) | participant | 511˙868.00 |
| 5 | UNIVERSITEIT MAASTRICHT | NL (MAASTRICHT) | participant | 510˙748.00 |
| 6 | KATHOLIEKE UNIVERSITEIT LEUVEN | BE (LEUVEN) | participant | 501˙120.00 |
| 7 | UNIVERZA V MARIBORU | SI (MARIBOR) | participant | 469˙995.00 |
| 8 | KEMIRA OYJ | FI (HELSINKI) | participant | 269˙145.00 |
| 9 | PREDILNICA LITIJA DOO | SI (LITIJA) | participant | 234˙997.00 |
| 10 | Bcomp Ltd | CH (Fribourg) | partner | 0.00 |
| 11 | BILLERUDKORSNAS AKTIEBOLAG (PUBL) | SE (SOLNA) | partner | 0.00 |
| 12 | EDUCELL PODJETJE ZA CELICNO BIOLOGI JO DOO | SI (TRZIN) | partner | 0.00 |
| 13 | ITA TECHNOLOGIETRANSFER GMBH | DE (AACHEN) | partner | 0.00 |
| 14 | MONDI AG | AT (WIEN) | partner | 0.00 |
| 15 | TETRA PAK PACKAGING SOLUTIONS AB | SE (LUND) | partner | 0.00 |
| 16 | UNIVERSITAETSKLINIKUM AACHEN | DE (AACHEN) | partner | 0.00 |
FibreNet will train young fibre-professionals having multidisciplinary view to develop sustainable bio-based fibre products with tailored properties for different application fields in both academic and non-academic sectors. Bio-based fibre products are one of the corner-stones in the European bio-based industry corresponding to 12% of the employment in manufacturing. The industry, including such sectors as packaging, paper, biocomposites and biomedical and hygienic textiles, is currently undergoing a fundamental transformation in order to respond to the competition raised i) by low-wage countries and ii) by fossil-based materials. A common consensus in Europe is that to remain competitive and sustain the bio-based fibre industries in Europe, we should focus on developing new high added value products that have specific functionalities but reduced environmental impacts.
In fibre-based products, developing new properties and improving the performance are, however, typically long and time-consuming processes. They usually involve massive and expensive laboratory and pilot-scale trials, which are followed by statistical analyses. There is a particular knowledge gap in understanding the influence of fibre and fibre interface properties on the mechanical properties of the end-product especially when developing products with tailored performance and functionalities. In addition to the research gap, there is a training gap in Europe, as we do not currently have a training programme which would educate professionals having a skill set needed for the fibre-centered approach that we propose in FibreNet.
To fill the research and training gaps, we propose here a unique training and research network which provides and further develops knowhow, methods and tools in functionalization, characterization, numerical modelling and production of bio-based fibre products at multiple length scales. The network covers expertise on packaging, paper, biocomposites and biomedical textiles.
| 1st network-wide training event | Other | 2020-02-27 15:02:56 |
| Online platform ready and running | Websites, patent fillings, videos etc. | 2020-02-27 15:03:11 |
| Educational parts of the online platform ready | Websites, patent fillings, videos etc. | 2020-02-27 15:02:56 |
| 2nd network-wide training event | Other | 2020-02-27 15:03:04 |
| Project web site published | Websites, patent fillings, videos etc. | 2020-02-27 15:03:01 |
| 3rd network-wide training event | Other | 2020-02-27 15:02:58 |
Take a look to the deliverables list in detail: detailed list of FibreNet deliverables.
| year | authors and title | journal | last update |
|---|---|---|---|
| 2019 |
Georg Urstöger, Monica G. Simoes, Andreas Steinegger, Robert Schennach, Ulrich Hirn Evaluating the degree of molecular contact between cellulose fiber surfaces using FRET microscopy published pages: 7037-7050, ISSN: 0969-0239, DOI: 10.1007/s10570-019-02575-x |
Cellulose 26/12 | 2019-12-17 |
| 2019 |
Vedad Tojaga, Selcuk Hazar, Sören Östlund Compressive failure of fiber composites containing stress concentrations: Homogenization with fiber-matrix interfacial decohesion based on a total Lagrangian formulation published pages: 107758, ISSN: 0266-3538, DOI: 10.1016/j.compscitech.2019.107758 |
Composites Science and Technology 182 | 2019-12-16 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "FIBRENET" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "FIBRENET" are provided by the European Opendata Portal: CORDIS opendata.
Self-Assembled MicroCAPSules: Synthesis, Characterization, and Eco-friendly Application in Home Care Products
Read MoreTraining innovative future leaders in research and development of materials and implants for the spine
Read MoreINnovation in Safety Pharmacology for Integrated cardiovascular safety assessment to REduce adverse events and late stage drug attrition.
Read More